NORETHIN 1/50M-28 pharmaceutical API fine chemical vendors

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
BenchChem	⤷ Get Started Free	B1200416	⤷ Get Started Free
THE BioTek	⤷ Get Started Free	bt-1540714	⤷ Get Started Free
RR Scientific	⤷ Get Started Free	R5270913	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 13, 2025

Introduction

NORETHIN 1/50M-28 is a combination oral contraceptive containing 1 mg of norethindrone and 50 mcg of ethinyl estradiol, administered over a 28-day regimen. As a widely prescribed hormonal contraceptive, its effectiveness and safety depend significantly on the stability and purity of its active pharmaceutical ingredients (APIs). Ensuring a reliable supply of high-quality APIs is crucial for manufacturers seeking to produce NORETHIN 1/50M-28, especially given the strict regulatory standards.

This article explores the primary sources for bulk APIs used in the production of NORETHIN 1/50M-28, emphasizing their manufacturing locations, certifications, quality standards, and market dynamics. It aims to assist pharmaceutical companies, procurement professionals, and stakeholders in identifying reliable API suppliers for this contraceptive formulation.

Understanding the API Components

Norethindrone

Norethindrone is a synthetic progestin used extensively in contraceptives. Its chemical synthesis involves multi-step processes, typically requiring raw materials sourced from specialized chemical intermediates.

Ethinyl Estradiol

Ethinyl estradiol is a synthetic derivative of estradiol with enhanced oral bioavailability. Its production involves complex chemical synthesis stages, often utilizing plant-derived or petrochemical feedstocks.

Global API Manufacturing Regions

The sourcing of APIs like norethindrone and ethinyl estradiol primarily occurs across certain key regions:

India: Major global supplier, with numerous GMP-certified manufacturers capable of producing high-purity APIs at competitive prices.
China: Growing presence with large-scale API production hubs, increasingly adhering to international quality standards.
Europe: Suppliers often possess stricter regulatory oversight, offering high-quality APIs, often used for export to regulated markets.
United States: Fewer manufacturers but notable for rigorous quality control and compliance with FDA standards.

Key API Suppliers and Manufacturers

Indian API Manufacturers

India hosts the majority of globally recognized API producers with extensive certifications such as WHO-GMP and USFDA approval.

Sun Pharmaceutical Industries Ltd.
- Offers a broad portfolio of hormonal APIs, including norethindrone and ethinyl estradiol.
- Facilities compliant with USFDA, WHO-GMP, and European standards.
- Known for high-volume production, competitive pricing, and global distribution.
Hetero Labs Ltd.
- Specializes in steroidal APIs used in contraceptives.
- Complies with international quality standards, with a considerable market share in hormonal API supply.
Aurobindo Pharma Ltd.
- Offers a range of oral contraceptive APIs, including norethindrone and ethinyl estradiol.
- Strong R&D presence with regulatory approvals from multiple agencies.

Chinese API Suppliers

Shenzhen Hepalink Pharmaceutical Group
- Produces hormone APIs including norethindrone for global markets.
- Focus on high-volume manufacturing and adherence to cGMP standards.
Qilu Pharmaceutical
- Offers a range of steroidal APIs, including ethinyl estradiol.
- Certified for export in regulated markets, maintaining strict quality controls.

European and North American Suppliers

BASF and Evonik Industries (Europe)
- Suppliers of high-purity chemicals and intermediates used in API synthesis.
- Emphasis on sustainable manufacturing practices with comprehensive quality assurance.
CordenPharma (USA/EU)
- Provides custom manufacturing and bulk APIs manufactured with high stringent quality standards, including sterile hormonal APIs.

Quality Assurance & Regulatory Compliance

Manufacturers supplying APIs for contraceptive products must meet stringent regulatory requirements, including:

Good Manufacturing Practices (GMP): Ensuring consistency, safety, and efficacy.
Regulatory Certifications: WHO-GMP, USFDA, EMA approvals.
Analytical Testing & Purity Standards: Identity, potency, impurity profile, residual solvents, microbiological limits.

Most reputable suppliers provide comprehensive Certificates of Analysis (CoA) and comply with international pharmacopoeial standards like USP, EP, or BP.

Market Dynamics & Sourcing Considerations

Pricing and Supply Stability

India remains the dominant source for cost-effective, high-volume APIs, driven by its extensive manufacturing infrastructure. Chinese manufacturers are increasingly aligning with international quality standards, offering competitive pricing and scalable supply chains.

Intellectual Property & Patent Landscape

Norethindrone and ethinyl estradiol API patents have largely expired, enabling generic manufacturers to produce these APIs freely. Nonetheless, regulatory confidentiality and proprietary synthesis routes may influence sourcing options.

Supply Chain Risks

Dependence on geopolitical factors, pandemic-related disruptions, or regulatory changes can impact API availability. Diversifying suppliers across regions and ensuring supplier qualification are critical strategies.

Procurement Strategies

Due Diligence: Vet suppliers based on regulatory compliance, quality certifications, and manufacturing capacity.
Long-term Agreements: Establish contracts for reliable, consistent supply.
Quality Audits: Conduct site audits and review analytical data before engagement.
Bulk Purchasing: Leverage volume discounts while maintaining quality oversight.

Conclusion

Reliable sourcing of bulk APIs for NORETHIN 1/50M-28 hinges on selecting reputable manufacturers with proven quality standards, regulatory compliance, and robust supply chains. Indian and Chinese manufacturers dominate the market, offering cost-effective options that meet international quality benchmarks. Engaging with suppliers certified under WHO-GMP, USFDA, or EMA standards remains preferable for finished pharmaceutical products destined for regulated markets.

Key Takeaways

India is the primary global source for high-quality norethindrone and ethinyl estradiol APIs, supported by numerous WHO-GMP and USFDA-approved manufacturers.
Chinese API producers are increasingly compliant with international standards, providing cost-effective options for global supply.
European and North American suppliers often focus on high-quality intermediates and specialty chemicals, crucial for ensuring API purity.
Ensuring regulatory compliance and conducting thorough supplier due diligence are vital for minimizing supply risks.
Diversification of API sources, combined with long-term contractual agreements, enhances supply chain resilience for NORETHIN 1/50M-28 production.

FAQs

1. What are the leading geographic regions for sourcing APIs used in contraceptives like NORETHIN?
India and China lead due to their extensive manufacturing infrastructure and cost advantages. Europe and North America focus on high-quality, regulated supplies.

2. How can manufacturers verify the quality of bulk APIs before procurement?
Through reviewing Certificates of Analysis, conducting third-party analytical testing, and visiting manufacturing sites during audits under GMP standards.

3. Are there regulatory concerns when sourcing from Chinese API manufacturers?
Yes. It’s essential to ensure that Chinese suppliers comply with international standards like GMP, and have the necessary certifications (e.g., cGMP, ISO). Switching suppliers or certification audits mitigate risks.

4. How do patent laws influence API sourcing for generic contraceptives?
Most patents for norethindrone and ethinyl estradiol have expired, enabling multiple manufacturers to produce generic APIs freely, increasing market competitiveness.

5. What are the risks associated with API supply chain disruptions?
Potential risks include geopolitical issues, regulatory changes, quality lapses, or pandemic-related disruptions. Supply diversification and proactive quality assurance mitigate these risks.

References

[1] Pharmaceutical Commerce. "Global API Market Overview." 2022.
[2] World Health Organization. " WHO Good Manufacturing Practices for Pharmaceutical Products." 2018.
[3] US Food and Drug Administration. "Guidance for Industry: Quality Systems Approach to Pharmaceutical Quality." 2017.
[4] CPhI Market Insights Report. "API Market Trends & Dynamics." 2021.
[5] Indian Drugs & Pharmaceuticals Ltd. "API Manufacturing Capabilities." 2022.

Bulk Pharmaceutical API Sources for NORETHIN 1/50M-28